Dose Adjustments to Concomitant Antiseizure Medications: Post-hoc Analysis of a Phase 3, Open-Label Study of Cenobamate for Treatment of Uncontrolled Focal Seizures

被引：0
|
作者：
Rosenfeld, William E. [1 ]
Abou-Khalil, Bassel [2 ]
Aboumatar, Sami [3 ]
Bhatia, Perminder [4 ]
Biton, Victor [5 ]
Klein, Pavel [6 ]
Krauss, Gregory L. [7 ]
Sperling, Michael R. [8 ]
Vossler, David G. [9 ]
Wechsler, Robert [10 ]
机构：
[1] Comprehens Epilepsy Care Ctr Children & Adults, New York, NY USA
[2] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[3] Austin Epilepsy Care Ctr, Austin, TX USA
[4] Neuro Pain Med Ctr, Fresno, CA USA
[5] Arkansas Epilepsy Program, Little Rock, AR USA
[6] Mid Atlantic Epilepsy & Sleep Ctr, North Bethesda, MD USA
[7] Johns Hopkins Univ, Baltimore, MD 21218 USA
[8] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA
[9] Univ Washington, Sch Med, Seattle, WA 98195 USA
[10] Idaho Comprehens Epilepsy Ctr, Boise, ID USA
来源：
NEUROLOGY | 2021年 / 96卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1755
引用
收藏
页数：5
相关论文
共 50 条
  • [41] A multivariable prediction model of a major treatment response for focal-onset seizures: A post-hoc analysis of Phase III trials of perampanel
    Krauss, Gregory L.
    Ben-Menachem, Elinor
    Wechsler, Robert T.
    Patten, Anna
    Williams, Betsy
    Laurenza, Antonio
    Malhotra, Manoj
    EPILEPSY RESEARCH, 2021, 174
  • [42] Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Sequel)
    Mueller, Ruediger B.
    Schulze-Koops, Hendrik
    Furst, Daniel E.
    Cohen, Stanley B.
    Kwok, Kenneth
    Wang, Lisy
    Killeen, Tim
    von Kempis, Johannes
    CLINICAL RHEUMATOLOGY, 2022, 41 (04) : 1045 - 1055
  • [43] Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Sequel)
    Ruediger B. Mueller
    Hendrik Schulze-Koops
    Daniel E. Furst
    Stanley B.  Cohen
    Kenneth Kwok
    Lisy Wang
    Tim Killeen
    Johannes von Kempis
    Clinical Rheumatology, 2022, 41 : 1045 - 1055
  • [44] MANAGEMENT OF MENORRHAGIA IN A PHASE 3, POST-HOC, OPEN-LABEL STUDY OF RECOMBINANT VON WILLEBRAND FACTOR (RVWF) IN PATIENTS WITH SEVERE VON WILLEBRAND DISEASE (VWD)
    Windyga, J.
    Castaman, G.
    Ozen, G.
    Ploder, B.
    Berthoz, F. Truong
    HAEMOPHILIA, 2020, 26 : 138 - 138
  • [45] Efficacy and safety of adjunctive perampanel in patients with focal seizures or generalized tonic-clonic seizures: Post hoc analysis of Phase II and Phase III double-blind and open-label extension studies in India
    Mehndiratta, Man M.
    Gulhane, Manoj
    Jabeen, Shaik A.
    Patten, Anna
    Dash, Amitabh
    Malhotra, Manoj
    EPILEPSIA OPEN, 2021, 6 (01) : 90 - 101
  • [46] Safety and Effectiveness of Long-Term Treatment with Lurasidone in Older Adults with Bipolar Depression: Post-Hoc Analysis of a 6-Month, Open-Label Study
    Forester, Brent P.
    Sajatovic, Martha
    Tsai, Joyce
    Pikalov, Andrei
    Cucchiaro, Josephine
    Loebel, Antony
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2018, 26 (02): : 150 - 159
  • [47] EFFECT OF COMMON CONCOMITANT ANTIEPILEPTIC DRUGS DURING ADJUNCTIVE TREATMENT WITH PERAMPANEL: POST HOC ANALYSIS FROM THE OPEN-LABEL EXTENSION OF A PHASE III STUDY IN PATIENTS WITH IDIOPATHIC GENERALISED EPILEPSY
    O'Brien, Terence J.
    Bibbiani, Francesco
    Patten, Anna
    Laurenza, Antonio
    Williams, Betsy
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (06): : E23 - E23
  • [48] Effect of Common Concomitant Antiepileptic Drugs during Adjunctive Treatment with Perampanel: Post Hoc Analysis from the Open-Label Extension of a Phase III Study in Patients with Idiopathic Generalised Epilepsy
    O'Brien, T. J.
    Bibbiani, F.
    Patten, A.
    Laurenza, A.
    Williams, B.
    EPILEPSIA, 2018, 59 : S75 - S75
  • [49] Lipid profile with eslicarbazepine acetate and carbamazepine monotherapy in adult patients with newly diagnosed focal-onset seizures: Post-hoc analysis from a phase III, randomized, double-blind study and a 2-year open-label extension ESL study
    Trinka, Eugen
    Rocamora, Rodrigo
    Moreira, Joana
    Pereira, Ana
    Fonseca, Miguel
    Fernandez, Guillermo Castilla
    Ikedo, Fabio
    NEUROLOGY, 2021, 96 (15)
  • [50] Efficacy Sustained After Dose De-escalation of Certolizumab Pegol in Rheumatoid Arthritis Patients: Post-hoc Analysis of the RAPID 2 Open-label Extension
    Smolen, Josef
    Van Vollenhoven, Ronald
    Kavanaugh, Arthur
    Luijtens, Kristel
    Van der Heijde, Desiree
    Curtis, Jeffrey
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (06) : 1153 - 1153
12345